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ABSTRACT: Rare functionally defective carboxypeptidase A1 (CPA1) variants have been 
reported to predispose to nonalcoholic chronic pancreatitis, mainly the idiopathic subtype. 
However, independent replication has so far been lacking, particularly in Asian cohorts where 
initial studies employed small sample sizes. Herein we performed targeted next-generation 
sequencing of the CPA1 gene in 1112 Han Chinese idiopathic chronic pancreatitis (ICP) 
patients – the largest ICP cohort so far analyzed in a single population – and 1580 controls. 
Sanger sequencing was used to validate called variants, and the CPA1 activity and secretion 
of all newly found variants were measured. A total of 18 rare CPA1 variants were 
characterized, 11 of which have not been previously described. However, no significant 
association was noted with ICP irrespective of whether all rare variants [20/1112 (1.8%) in 
patients vs. 24/1580 (1.52%) in controls; P=0.573] or functionally impaired variants [3/1112 
(0.27%) in patients vs. 2/1580 (0.13%) in controls; P=0.410] were considered.  
 
KEY WORDS: CPA1 gene; idiopathic chronic pancreatitis; missense mutations; next-
generation sequencing; rare variants 
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Since the identification of a gain-of-function missense mutation in the PRSS1 gene (encoding 
cationic trypsinogen; MIM# 276000) as a cause of autosomal dominant hereditary pancreatitis 
(MIM# 167800) 20 years ago [Whitcomb et al., 1996], heritable variants in multiple genes 
have been reported to cause, predispose to, or protect against several forms of chronic 
pancreatitis (see [Fjeld et al., 2015] and references therein). Some of these genetic 
associations have been consistently replicated in independent studies, and the underlying 
pathogenic mechanisms elucidated. In particular, findings from the analysis of four genes 
abundantly expressed in pancreatic acinar cells − PRSS1 [Le Maréchal et al., 2006; Whitcomb 
et al. 1996; Whitcomb et al., 2012], PRSS2 (encoding anionic trypsinogen; MIM# 601564) 
[Witt et al., 2006], SPINK1 (encoding pancreatic secretory trypsin inhibitor; MIM# 167790) 
[Witt et al., 2000] and CTRC (encoding chymotrypsin C, which specifically degrades all 
human trypsinogen/trypsin isoforms [Szmola and Sahin-Tóth 2007]; MIM# 601405) [Masson 
et al., 2008; Rosendahl et al., 2008] − have established the importance of a balance between 
the activation and inactivation of trypsinogen within the pancreas, thereby defining a trypsin-
dependent pathway as a key component of the pathogenesis of chronic pancreatitis. 
Procarboxypeptidase A1, the inactive form of the digestive enzyme carboxypeptidase A1 
(CPA1; MIM# 114850), is the second most abundantly synthesized protein after trypsinogen 
in the pancreatic juice [Scheele et al., 1981]. In addition, procarboxypeptidase A1 is a 
component of the pancreatic zymogen activation cascade which, if prematurely activated 
within the pancreas, could potentially lead to pancreatic autodigestion [Chen and Férec, 
2009]. Recently, a candidate gene approach [Witt et al., 2013] identified an 
overrepresentation of functionally impaired CPA1 variants (defined as exhibiting enzymatic 
activity <20% of the wild-type in the conditioned medium of transfected cells) in German 
patients with nonalcoholic chronic pancreatitis (NACP) as compared to controls. Functionally 
impaired CPA1 variants were also found to be significantly overrepresented in NACP patients 
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as compared to controls in a European replication cohort (mainly French, Czech and Polish) 
and two small Asian cohorts, albeit with much lower odds ratios (OR) and much higher P 
values (see Table 1). It should be noted that (i) the NACP patients were mainly subjects with 
idiopathic chronic pancreatitis (ICP) along with a few cases with a family history of chronic 
pancreatitis and (ii) the <20% cut-off value for defining functionally defective CPA1 variants 
was set relative to p.Thr124Ile, a low-frequency variant (defined as having a minor allele 
frequency of 0.5%-5% in the control population as previously described [Manolio et al., 2009; 
Tennessen et al., 2012]) that was present with equal frequency in both German NACP patients 
and controls, and which exhibited 23% of the activity of the wild-type CPA1 enzyme [Witt et 
al. 2013]. Additionally, it is important to mention two other findings in the German discovery 
population. First, the association between defective CPA1 variants and NACP was strongest 
in those German patients aged ≤10 years, in whom the detection frequency was nearly 10% 
(22/228), with the corresponding OR reaching 84.0. Second, defective CPA1 variants were 
found in only 2/465 (0.4%) German patients with alcohol-related chronic pancreatitis, 
suggesting only a very minor role in this disease subtype [Witt et al. 2013].  
In the previous study, most of the functionally impaired CPA1 variants were found only in 
patients. For those variants that were found in both patients and controls, or only in controls, 
their minor allele frequencies in the control population(s) were invariably <0.5% [Witt et al. 
2013]. Therefore, all the functionally impaired CPA1 variants naturally fell into the category 
of rare variants [Manolio et al. 2009; Tennessen et al. 2012]. Biochemical studies revealed no 
detectable impact of CPA1 on trypsinogen activation, trypsin activity, or the degradation of 
trypsin and trypsinogen by CTRC, suggesting a trypsin-independent pathogenic mechanism 
underlying the functionally impaired CPA1 variants [Witt et al. 2013]. Importantly, the 
defective CPA1 variants were often characterized by significantly decreased secretion, 
intracellular retention and degradation, implying involvement of misfolding-induced 
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endoplasmic reticulum stress, as previously observed in a subset of rare PRSS1 and CTRC 
variants [Beer et al., 2013; Kereszturi et al., 2009; Németh et al., 2016; Schnúr et al., 2014]. 
Indeed, expression of the CPA1 p.Asn256Lys variant, which was found in 7 NACP patients 
but not in controls, resulted in endoplasmic reticulum (ER) stress in AR42J rat acinar cells 
[Witt et al. 2013]. More recently, a novel CPA1 variant, p.Ser282Pro, found in two Polish 
families with hereditary pancreatitis, has been shown to induce ER stress to a comparable 
degree as the p.Asn256Lys variant [Kujko et al., 2017]. 
Given the remarkable differences in the occurrence and distribution of rare functional 
CPA1 variants among the different populations, and the small sizes of the two Asian cohorts 
analyzed to date (Table 1), further independent replication in larger studies is clearly 
warranted [MacArthur et al., 2014]. Herein we report the targeted sequencing of the CPA1 
gene in a large cohort of Han Chinese ICP patients. All 1112 Chinese ICP patients (776 males 
and 336 females) were of Han origin. A clinical diagnosis of ICP was made as previously 
described [Zou et al., 2016] (see also Supp. Methods). The 1580 healthy controls were 
unrelated Han Chinese blood donors. Informed consent was obtained from each patient and 
the study was approved by the Changhai Hospital’s Ethics Committee.  
We designed a total of 16 target-specific primer pairs (Supp. Figure S1) for the coding 
sequence and exon/intron boundaries of the CPA1 gene (human GRCh37/hg19 
https://genome.ucsc.edu/; NM_001868.3) using Primer3 (http://simgene.com/Primer3) 
[Untergasser et al., 2012]. The primers were synthesized with common adaptor sequences at 
their 5’ ends as previously described [Forshew et al., 2012]. The 16 primer pairs were divided 
into two multiplex primer pools. Pre-amplification of the tagged-CPA1 amplicons, generation 
of a barcoded DNA library for multiplex high-throughput sequencing, quantification and 
clean-up of the DNA library and sequencing were performed essentially as previously 
described [Forshew et al. 2012]. The raw paired 150 bp-long reads were aligned to the human 
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reference genome (build hg19) using the Burrows-Wheeler Aligner (BWA version 0.5.9). The 
Genome Analysis Toolkit (GATK, version 3.1) was then used to perform local realignment 
and to recalibrate base quality scores, yielding a cleaned BAM file for each individual. The 
raw single nucleotide variants and small insertions or deletions were filtered based upon the 
variant quality score recalibration module in GATK. Had we added the step “QD < 2.0” to the 
SNV (single nucleotide variants) filtration process, most of the mutations located at the target-
specific primer regions would have been missed, leading to false negative results. To avoid 
such a situation, the raw SNVs were simply filtered by the VariantFiltration module in GATK 
using the following steps: (i) MQ < 40.0, (ii) MQRankSum < -12.5 and (iii) 
ReadPosRankSum < -8.0; and the raw INDELs were only filtered by the VariantFiltration 
module in GATK using the following arguments: (i) ReadPosRankSum <-20.0 and (ii) 
FS>200.0. This approach was bound to generate false positive findings, which were then 
excluded by manual inspection of each called variant using the Integrative Genomics Viewer 
followed by validation by Sanger sequencing. Given that all the previously reported 
functionally defective CPA1 variants [Witt et al. 2013] fell into the category of rare variants, 
we only included variants for analysis which were absent or occurred with a minor allele 
frequency of <0.5% in the public database of the 1000 Genomes Project 
(http://www.1000genomes.org/) [Auton et al., 2015; Sudmant et al., 2015]. In case of SNVs, 
only those that occurred within canonical splice sites or were predicted to result in a 
premature stop codon or missense mutations were included for analysis. The types of variant 
under consideration followed the earlier report [Witt et al. 2013], and included (i) small 
deletions or insertions that occurred within the canonical splice sites and coding sequence and 
(ii) single nucleotide substitutions that altered either canonical splice sites or else resulted in 
missense or nonsense mutations. All called rare variants were subjected to validation by 
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Sanger sequencing. Sequences of the primers used to amplify the fragments of interest are 
provided in Supp. Figure S2. 
Under the conditions of our targeted sequencing approach, we initially discovered 30 rare 
CPA1 variants in 60 subjects. The various exons harboring these variants were then PCR 
amplified from the 60 carriers; subsequent Sanger sequencing of the resulting PCR products 
confirmed the presence of 18 variants in 44 subjects. The 18 validated variants spanned all ten 
exons of the CPA1 gene, were all detected in the heterozygous state and were all single 
nucleotide substitutions that were predicted to result in missense mutations. Nearly two thirds 
(N = 11) of the 18 variants had not been previously described (Table 2). It is possible that 
some rare variants were missed by this method. However, this is unlikely to be a major issue 
for two reasons. First, we found variants in all 10 exons of the CPA1 gene. Second, to avoid 
false negative results, we used rather relaxed parameters for variant calling, as evidenced by 
the high false positive rate. As indicated, false positive variants were eliminated by an 
independent PCR followed by Sanger sequencing. 
The 18 rare CPA1 variants were present in 20 (1.80%) of the 1112 Chinese ICP patients 
and in 24 (1.52%) of the 1580 controls (Table 2), indicating no significant difference between 
the two groups (P = 0.573, 2-tailed Fisher’s exact test); Supp. Table S1). For comparison, we 
tested the association of all rare variants and NACP in the context of each previously 
published NACP cohort [Witt et al. 2013]: no association was observed in the European 
replication cohort whereas a positive association was observed in each of the German, Indian 
and Japanese NACP cohorts (Supp. Table S1). We then investigated whether there might be 
an association between rare functionally defective CPA1 variants and ICP in the Chinese 
cohort. To this end, we functionally characterized all 11 newly found rare variants in terms of 
their CPA1 activity and secretion as previously described [Witt et al. 2013] (for detailed 
description, see Supp. Methods). The activities and secretion levels determined for the new 
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CPA1 variants relative to the wild-type values are summarized in Table 2 (Miklos: a Supp. 
Figure showing a gel photo here?). Also shown are the CPA1 activity and secretion data for 
the 7 known variants taken from Witt et al. [Witt et al. 2013]. We designated CPA1 variants 
functionally defective if the carboxypeptidase activity in the conditioned medium measured 
after activation with trypsin and chymotrypsin C was lower than 20% of the wild-type value 
in accordance with [Witt et al. 2013]. This reduced activity could be the result of decreased 
secretion, impaired catalytic activity or degradation by the activating proteases. Functionally 
defective CPA1 variants were found in 3 (p.Gly225Ser × 1, p.His306Tyr × 1 and 
p.Glu380Lys × 1) of the 1,112 (0.27%) Chinese ICP patients and in 2 (p.Glu100Lys × 1, and 
p.Arg240Gln × 1) of the 1,580 (0.13%) controls (Table 2), again displaying no significant 
difference (P = 0.68; Table 1). As mentioned earlier, the association between defective CPA1 
variants and NACP was at its strongest for the German patients aged ≤10 years, the 
corresponding detection frequency was nearly 10% [Witt et al. 2013]. The Chinese ICP cohort 
contained only 61 patients aged ≤10 years, but none of these individuals was found to harbor 
a functionally defective variant.  
There is one additional point to make. Functionally impaired CPA1 missense variants have 
previously been reported to occur predominantly in the second half of the 419-amino acid-
protein [Witt et al. 2013]. Consistent with this finding, four of five such variants found in the 
Chinese subjects were also located in the second half of the protein (Table 2). Evaluation of 
all the functionally impaired CPA1 missense variants in the context of the CPA1 structure 
(http://www.uniprot.org/uniprot/P15085) revealed that p.Arg237His, p.His306Tyr and 
p.Glu380Lys affected substrate binding or catalytic sites whereas p.Cys271Arg affected a 
disulfide bond-forming residue (Supp. Figure S3). It should be noted that all five variants 
occurred in the second half of the CPA1 protein sequence. 
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In summary, this is the first study to attempt to replicate the recently reported association 
of rare functional CPA1 variants with chronic pancreatitis [Witt et al. 2013] in the context of a 
large ICP cohort. This is also the largest ICP cohort to date used for the sequencing of the 
entire coding region and exon/intron boundaries of the CPA1 gene in a single population. 
Often, the OR of an association observed in a discovery cohort is much higher than in 
subsequent replication cohorts [Dumas-Mallet et al., 2016]; this was indeed the case for the 
rare functional CPA1 variants in the German, European replication and Asian cohorts (Table 
1). However, no significant association with ICP was noted in our Chinese cohort, 
irrespective of whether all rare variants or functionally-deficient variants were considered. 
Differences in phenotype definition and ethnicity-specific disease risk factors as well as 
population stratification may account for the inconsistent findings between studies. For 
example, although both the present study and the previous study focused on non-alcoholic 
patients (Table 1), differences between the cohorts regarding alcohol consumption (even if not 
in causative dosage), smoking and age could conceivably have contributed to the observed 
differences in disease association. Additionally, given that the proposed disease mechanism is 
provoked ER stress [Witt et al. 2013], the possibility that CPA1 activity might not be the best 
proxy marker for the functional effect of the disease-associated CPA1 variants remains to be 
excluded.  
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